Uncategorized

Celltrion presents strategic vision and growth plan at the 42nd Annual J.P. Morgan Healthcare Conference

Celltrion, Inc. announced the next phase of its strategic transformation from a developer of the world’s first monoclonal antibody biosimilar to an innovative company focused on new drug development at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, Calif.

Celltrion presents strategic vision and growth plan at the 42nd Annual J.P. Morgan Healthcare Conference Read More »

Scroll to Top